Synthase Biotech

New Zealand
Hamilton, Waikato Region, New Zealand, 3214

Company profile

Synthase Biotech company profile

Synthase Biotech aim to develop, manufacture and supply well-designed high quality life-extension enzyme technologies for the benefit of humans, animals and the environment.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-01-01

Headquarters

Postal code
3214
Country code
NZ
Continent
Oceania

Capital profile

Funding and company signals

Funding rounds
7
Total equity funding
$5M
Last funding
Grant / $5,635 / 2022-09-15
Last equity funding
Series Unknown / $3.4M
Investors
5
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Dr Andrew West

Lead investors

Callaghan Innovation

Investors

Callaghan InnovationEnterprise AngelsIce AngelsMatū GroupNew Zealand Venture Investment Fund